0001209191-23-023385.txt : 20230405 0001209191-23-023385.hdr.sgml : 20230405 20230405171009 ACCESSION NUMBER: 0001209191-23-023385 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230403 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Collard Craig A CENTRAL INDEX KEY: 0001363558 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33221 FILM NUMBER: 23803419 BUSINESS ADDRESS: BUSINESS PHONE: 919-678-6611 MAIL ADDRESS: STREET 1: C/O CORNERSTONE THERAPEUTICS INC. STREET 2: 1255 CRESCENT GREEN DRIVE, SUITE 250 CITY: CARY STATE: NC ZIP: 27518 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HERON THERAPEUTICS, INC. /DE/ CENTRAL INDEX KEY: 0000818033 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942875566 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8582514400 MAIL ADDRESS: STREET 1: 4242 CAMPUS POINT COURT, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: AP PHARMA INC /DE/ DATE OF NAME CHANGE: 20010511 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED POLYMER SYSTEMS INC /DE/ DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-03 0 0000818033 HERON THERAPEUTICS, INC. /DE/ HRTX 0001363558 Collard Craig A 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 1 1 0 0 Chief Executive Officer 0 Employee Stock Option (Right to Buy) 1.78 2023-04-03 4 A 0 3000000 0.00 A 2033-04-03 Common Stock 3000000 3000000 D Restricted Stock Units 0.00 2023-04-03 4 A 0 250000 0.00 A Common Stock 250000 250000 D Employee Performance Stock Option (Right to Buy) 1.78 2023-04-03 4 A 0 4250000 0.00 A 2033-04-03 Common Stock 4250000 4250000 D The stock option vests and becomes exercisable with respect to 750,000 shares on the first anniversary of the date of grant, followed by 2,250,000 shares vesting ratably each month over the subsequent three years, such that 3,000,000 options will be fully vested on the four-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date. The stock option vests and becomes exercisable with respect to escalating portions of the option grant upon the Issuer's stock price reaching certain pre-established levels ranging from $4.50 to $9.00 per share, subject to the Reporting Person's continued service to the Issuer through the vesting date. /s/ Lisa Peraza Attorney-in-fact for Craig A. Collard 2023-04-05